Denmark · Delayed Price · Currency is DKK Novo Nordisk Statistics
Total Valuation
Novo Nordisk has a market cap or net worth of DKK 1.52 trillion. The enterprise value is 1.60 trillion.
| Market Cap | 1.52T |
| Enterprise Value | 1.60T |
Important Dates
The next estimated earnings date is Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Aug 15, 2025 |
Share Statistics
Novo Nordisk has 4.44 billion shares outstanding. The number of shares has decreased by -0.57% in one year.
| Current Share Class | 3.37B |
| Shares Outstanding | 4.44B |
| Shares Change (YoY) | -0.57% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.02% |
| Owned by Institutions (%) | 29.94% |
| Float | 3.19B |
Valuation Ratios
The trailing PE ratio is 13.71 and the forward PE ratio is 14.33. Novo Nordisk's PEG ratio is 1.58.
| PE Ratio | 13.71 |
| Forward PE | 14.33 |
| PS Ratio | 4.87 |
| PB Ratio | 9.04 |
| P/TBV Ratio | 25.25 |
| P/FCF Ratio | 23.31 |
| P/OCF Ratio | 12.51 |
| PEG Ratio | 1.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.96, with an EV/FCF ratio of 24.54.
| EV / Earnings | 14.41 |
| EV / Sales | 5.13 |
| EV / EBITDA | 9.96 |
| EV / EBIT | 10.77 |
| EV / FCF | 24.54 |
Financial Position
The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.59.
| Current Ratio | 0.78 |
| Quick Ratio | 0.50 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 1.52 |
| Interest Coverage | 17.27 |
Financial Efficiency
Return on equity (ROE) is 79.17% and return on invested capital (ROIC) is 42.53%.
| Return on Equity (ROE) | 79.17% |
| Return on Assets (ROA) | 21.82% |
| Return on Invested Capital (ROIC) | 42.53% |
| Return on Capital Employed (ROCE) | 54.12% |
| Revenue Per Employee | 3.98M |
| Profits Per Employee | 1.42M |
| Employee Count | 77,349 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.20 |
Taxes
In the past 12 months, Novo Nordisk has paid 29.71 billion in taxes.
| Income Tax | 29.71B |
| Effective Tax Rate | 21.10% |
Stock Price Statistics
The stock price has decreased by -57.07% in the last 52 weeks. The beta is 0.33, so Novo Nordisk's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -57.07% |
| 50-Day Moving Average | 361.06 |
| 200-Day Moving Average | 455.95 |
| Relative Strength Index (RSI) | 40.91 |
| Average Volume (20 Days) | 4,990,547 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Novo Nordisk had revenue of DKK 311.94 billion and earned 111.07 billion in profits. Earnings per share was 24.95.
| Revenue | 311.94B |
| Gross Profit | 262.83B |
| Operating Income | 148.64B |
| Pretax Income | 140.78B |
| Net Income | 111.07B |
| EBITDA | 159.26B |
| EBIT | 148.64B |
| Earnings Per Share (EPS) | 24.95 |
Balance Sheet
The company has 18.93 billion in cash and 99.27 billion in debt, giving a net cash position of -80.33 billion or -18.08 per share.
| Cash & Cash Equivalents | 18.93B |
| Total Debt | 99.27B |
| Net Cash | -80.33B |
| Net Cash Per Share | -18.08 |
| Equity (Book Value) | 168.07B |
| Book Value Per Share | 37.82 |
| Working Capital | -44.82B |
Cash Flow
In the last 12 months, operating cash flow was 121.53 billion and capital expenditures -56.30 billion, giving a free cash flow of 65.22 billion.
| Operating Cash Flow | 121.53B |
| Capital Expenditures | -56.30B |
| Free Cash Flow | 65.22B |
| FCF Per Share | 14.68 |
Margins
Gross margin is 84.26%, with operating and profit margins of 47.65% and 35.61%.
| Gross Margin | 84.26% |
| Operating Margin | 47.65% |
| Pretax Margin | 45.13% |
| Profit Margin | 35.61% |
| EBITDA Margin | 51.06% |
| EBIT Margin | 47.65% |
| FCF Margin | 20.91% |
Dividends & Yields
This stock pays an annual dividend of 11.65, which amounts to a dividend yield of 3.41%.
| Dividend Per Share | 11.65 |
| Dividend Yield | 3.41% |
| Dividend Growth (YoY) | 17.68% |
| Years of Dividend Growth | 7 |
| Payout Ratio | 46.69% |
| Buyback Yield | 0.57% |
| Shareholder Yield | 3.98% |
| Earnings Yield | 7.31% |
| FCF Yield | 4.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.
| Last Split Date | Sep 13, 2023 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Novo Nordisk has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.82 |
| Piotroski F-Score | 4 |